Top Markets
#1 Black Phoenix Black Phoenix +2,481.31%
#2 Nesa Nesa +757.56%
#3 Ontology Gas Ontology Gas +146.87%
#4 ADO Protocol ADO Protocol +103.33%
#5 Cortex Cortex +95.09%
#6 Kinesis Silver Kinesis Silver +54.45%
#7 Pons Pons +33.01%
#8 Magma Finance Magma Finance +32.06%
#9 OpenEden OpenEden +31.63%
#10 Non-Playable Coin Non-Playable Coin +31.55%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Classificação em ações #18663
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Preço da ação
$0.15360289
Valor de mercado
$190.75M
Variação (1 dia)
6.25%
Variação (1 ano)
94.11%
País
NZ
Negociar Pacific Edge Limited (PEB)

Categoria

Healthcare
EPS de Pacific Edge Limited (PEB)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Pacific Edge Limited, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Pacific Edge Limited de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $18.62 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $5.65 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $-1.36 -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 $4.99 -
US